Medical Assurance

Nuffield Health champions and has implemented the IHPN, Medical Practitioners Assurance Framework along with other independent sector organisations to help to standardise medical governance across the sector to further drive the quality and safety of care for patients.


Patient notices about procedures

Metal on metal hip replacements

The Medicines Health and Regulatory Authority (MHRA) has revised its guidance on reviews for patients who have undergone metal on metal implant surgery.

The Medicines Health and Regulatory Authority (MHRA) has revised its guidance on reviews for patients who have undergone metal on metal implant surgery. As a result of the changes, all patients with these implants are now advised to have their blood metal level tested according to MHRA guidelines and some may require ultrasound or MRI scans.

As a result of this new guidance, Nuffield Health have contacted patients who we believe received Metal on Metal Implants at our hospitals.

If you were treated in a Nuffield Health hospital for a joint replacement and believe you received a metal on metal hip implant but have not yet been contacted by us, you can find out if you might be advised to be tested by contacting the Matron at the Nuffield Hospital you had your hip surgery. Contact details can be found here.

Transvaginal mesh for repair of anterior or posterior vaginal wall prolapse

Following the guidelines issued by NICE, Transvaginal mesh repair of anterior or posterior vaginal wall prolapse, we will be fully implementing their recommendations and will no longer be using mesh in this procedure.

There is currently no guidance from regulators regarding what if any action should be taken with those patients who have already undergone this procedure. Until such guidance is provided, we are not advising any interventions.

But we encourage any woman who has concerns and was treated at one of our hospitals to get in touch with us. They can call us on 0300 123 1907.

Paterson Inquiry

We welcome the publication of the Paterson Inquiry report. We have actively engaged with our trade IHPN and the Inquiry over the complex issues involved and how the independent sector, NHS and others must work together to resolve them in the interests of patients.

We have implemented the Medical Practitioners Assurance Framework (MPAF) throughout our hospitals and clinics and continue to contribute to discussions on how the sector can drive forward the best experience, safety and outcomes for the patients in our care.


Patient notices about case reviews

Mr Philip Kaloo review
An independent review of a select number of Mr Kaloo’s patients is taking place. We are contacting some of Mr Kaloo’s patients directly, asking them about any questions or feedback they have. We suspended Mr Kaloo’s practising privileges at our Nuffield Health Cheltenham Hospital in September 2019, following restrictions on his practice imposed by the NHS Trust at that time. For any patients who have questions or who wish to provide feedback, please contact us on 0300 790 6199, Monday to Friday between the hours of 09:00-17:00.

Professor Derek McMinn investigation

Following recent media coverage with allegations against a former consultant, Professor Derek McMinn, we would like to reassure patients that we will support the ongoing investigation by the GMC and BMI Healthcare.

Professor Derek McMinn was suspended in March 2019 from working at BMI Healthcare’s Edgbaston Hospital. This hospital was owned by Nuffield Health until 1 February 2008 and Professor Derek McMinn therefore worked with Nuffield Health up until this time when the hospital was sold to BMI Healthcare.

The care of our patients is our number one priority and we understand these allegations may be distressing for Prof McMinn’s former patients and their relatives. If any information concerning individuals that relates to patient harm is identified as the criminal investigation progresses, we will respond to the people concerned and provide any support they need. Please contact us 020 7935 0894 (selecting option 4) if you would like more information.

Mr Michael Walsh investigation

Following the recent media reports regarding a former consultant, we would like to reassure patients we are working with the GMC on their ongoing investigation into Mr Michael Walsh. The safety and welfare of our patients is our number one priority - we are actively reviewing Mr Michael Walsh’s historic patient cases and should any issues come to light we will contact patients directly. Due to patient confidentiality, we are unable to comment on specific cases. For any patients concerned, we advise them to contact the Nuffield Health Leeds Hospital on 0113 388 2000.


For further information, please email us revalidation@nuffieldhealth.com